Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage.

BBBd MRI PET hyperglycemia subarachnoid hemorrhage

Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
20 Sep 2023
Historique:
pubmed: 20 9 2023
medline: 20 9 2023
entrez: 20 9 2023
Statut: aheadofprint

Résumé

Hyperglycemia has been linked to worsening outcomes after subarachnoid hemorrhage (SAH). Nevertheless, the mechanisms involved in the pathogenesis of SAH have been scarcely evaluated so far. The role of hyperglycemia was assessed in an experimental model of SAH by T

Identifiants

pubmed: 37728631
doi: 10.1177/0271678X231197946
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271678X231197946

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ana Joya (A)

Achucarro Basque Center for Neuroscience, Leioa, Spain.
CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Sandra Plaza-García (S)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Daniel Padro (D)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Laura Aguado (L)

Achucarro Basque Center for Neuroscience, Leioa, Spain.
CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Leyre Iglesias (L)

Achucarro Basque Center for Neuroscience, Leioa, Spain.
Neurovascular Group, Biocruces Health Research Institute, Barakaldo, Spain.

Maider Garbizu (M)

Achucarro Basque Center for Neuroscience, Leioa, Spain.
CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Vanessa Gómez-Vallejo (V)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Carlos Laredo (C)

Institute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona, Barcelona, Spain.

Unai Cossío (U)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.

Ramon Torné (R)

Institute of Neuroscience, Neurosurgery Department, Hospital Clinic of Barcelona, Spain.

Sergio Amaro (S)

Institute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona, Barcelona, Spain.

Anna M Planas (AM)

Area of Neurosciences. Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Neuroscience and Experimental Therapeutics, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain.

Jordi Llop (J)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.
Centro de Investigación Biomédica en Red - Enfermedades Respiratorias, CIBERES, Madrid, Spain.

Pedro Ramos-Cabrer (P)

CIC biomaGUNE, Basque Research and Technology Alliance, San Sebastian, Spain.
Ikerbasque Basque Foundation for Science, Bilbao, Spain.

Carles Justicia (C)

Area of Neurosciences. Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Neuroscience and Experimental Therapeutics, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain.

Abraham Martín (A)

Achucarro Basque Center for Neuroscience, Leioa, Spain.
Ikerbasque Basque Foundation for Science, Bilbao, Spain.

Classifications MeSH